People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Moleculera Labs, Inc. | — | Biotechnology | Seed | $3.4M | $131.4M | 2012 |
| Dermamedics Llc | — | Pharmaceuticals | Pre-Seed | $2.0M | $45.9M | — |
David Thomison at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Thomison on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mike Allen | 1 | 3 |
| Craig Shimasaki, PhD, MBA | 1 | 1 |
| Fred Hiller | 1 | 1 |
| Dr. Madeleine Cunningham | 1 | 1 |
| Madeleine Cunningham | 1 | 1 |
| BRYAN FULLER | 1 | 1 |
| JACK MEYER | 1 | 1 |
| THANE SWISHER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.